The Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers is now available in the United States, providing broad clinical access to the minimally invasive prognostic tool. Currently, the ELF ...
BURLINGTON, N.C.--(BUSINESS WIRE)--For the millions of people in the United States living with an advanced form of chronic liver disease, simply understanding the potential for future complications ...
At present, transient elastography and the serum marker FibroTest are the most intensively evaluated non-invasive methods for the assessment of liver fibrosis. The results of the present study for ...
Disclaimer: The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. In the U.S., the ELF Test is indicated as a ...
Data from the Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE) study indicates Siemens Healthineers’ ELF Test as the top-performing biomarker NIMBLE, the largest biomarker consortium from ...
Background: FibroTest (FT) is the most frequently used serum fibrosis marker and consists of an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, GGT, bilirubin).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results